Tofacitinib in the treatment of refractory eczemas – a case series
Janus Kinase inhibitors have been shown to be effective in the treatment of various dermatoses such as alopecia areata, psoriasis, vitiligo and atopic dermatitis. The Janus kinase-signal transducer and activator of transcription (JAK-STAT) pathway is a common junction for the signaling of several de...
Main Authors: | Prasanna Duraisamy, Soumya Jagadeesan, Jacob Thomas |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-08-01
|
Series: | Journal of Dermatological Treatment |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/09546634.2022.2082355 |
Similar Items
-
JAK-inhibitors as rescue therapy in dupilumab-refractory severe atopic dermatitis: A case series of 6 patients
by: Neda Shahriari, MD, et al.
Published: (2023-03-01) -
Is it Just Simple Dermatitis or Eczema?
by: Öner Özdemir
Published: (2019-11-01) -
STUDY ON SOME FACTORS ASSOCIATED WITH ECZEMA IN RAMADI.
by: Abdulla S. Hassan, et al.
Published: (2012-06-01) -
New Perspectives in the Management of Chronic Hand Eczema: Lessons from Pathogenesis
by: Vittorio Tancredi, et al.
Published: (2023-12-01) -
Novel topical and systemic therapies in atopic dermatitis
by: Hiraku Suga, et al.
Published: (2019-04-01)